ArticlePharmacy practice2012

An analysis of the warning letters issued by the FDA to pharmaceutical manufacturers regarding misleading health outcomes claims.

Satabdi Chatterjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.